scorecardresearch
Tuesday, July 22, 2025
TopicMankind Pharma

Topic: Mankind Pharma

Income tax dept searches Mankind Pharma’s office in Delhi, CNBC TV18 reports

The company's shares fell as much as 5.5% on the news, which comes days after the condom maker listed on exchanges with sharp gains.

Mankind Pharma eyes $5 billion valuation in IPO

The IPO for the company will consist of nearly 40.1 million shares on offer for sale from existing shareholders, according to a prospectus.

Mankind Pharma receives DRDO license to manufacture, market Covid drug 2-DG

Drugs Controller General of India (DCGI) had permitted the emergency use of 2-DG on 1 May, as an adjunct treatment for moderate to severe Covid-19 patients.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.